Specifically, we measured the Spearman correlation coefficient R to evaluate the expression correlation of PRDM1, PRDM2 and their main transcripts on three datasets from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx): whole blood, thymoma normal and EBV-transformed lymphocytes. The gene discussed is PRDM2; the disease is thymoma.